190 related articles for article (PubMed ID: 34311608)
21. Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder.
Park MH; Chang KD; Hallmayer J; Howe ME; Kim E; Hong SC; Singh MK
J Psychiatr Res; 2015 Feb; 61():81-8. PubMed ID: 25498133
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J
Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419
[TBL] [Abstract][Full Text] [Related]
23. The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.
Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Yang YH; Lu RB; Chen CS
Sci Rep; 2016 Dec; 6():37950. PubMed ID: 27905499
[TBL] [Abstract][Full Text] [Related]
24. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.
Chepenik LG; Fredericks C; Papademetris X; Spencer L; Lacadie C; Wang F; Pittman B; Duncan JS; Staib LH; Duman RS; Gelernter J; Blumberg HP
Neuropsychopharmacology; 2009 Mar; 34(4):944-51. PubMed ID: 18704093
[TBL] [Abstract][Full Text] [Related]
25. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.
Lohoff FW; Sander T; Ferraro TN; Dahl JP; Gallinat J; Berrettini WH
Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):51-3. PubMed ID: 16152572
[TBL] [Abstract][Full Text] [Related]
26. Neurostructural correlates of BDNF rs6265 genotype in youth bipolar disorder.
Kennedy KG; Shahatit Z; Dimick MK; Fiksenbaum L; Freeman N; Zai CC; Kennedy JL; MacIntosh BJ; Goldstein BI
Bipolar Disord; 2022 Mar; 24(2):185-194. PubMed ID: 34263997
[TBL] [Abstract][Full Text] [Related]
27. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
Amare AT; Thalamuthu A; Schubert KO; Fullerton JM; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Hasler R; Richard-Lepouriel H; Perroud N; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Fallgatter AJ; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman JL; Kohshour MO; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich D; Figge C; Jäger M; Lang FU; Juckel G; Konrad C; Reimer J; Schmauß M; Schmitt A; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer TFM; Fischer A; Bermpohl F; Ritter P; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haussleiter IS; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Millischer V; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Clark SR; Baune BT
Mol Psychiatry; 2023 Dec; 28(12):5251-5261. PubMed ID: 37433967
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder.
Song J; Bergen SE; Di Florio A; Karlsson R; Charney A; Ruderfer DM; Stahl EA; ; Chambert KD; Moran JL; Gordon-Smith K; Forty L; Green EK; Jones I; Jones L; Scolnick EM; Sklar P; Smoller JW; Lichtenstein P; Hultman C; Craddock N; Landén M; Smoller JW; Perlis RH; Lee PH; Castro VM; Hoffnagle AG; Sklar P; Stahl EA; Purcell SM; Ruderfer DM; Charney AW; Roussos P; Michele Pato CP; Medeiros H; Sobel J; Craddock N; Jones I; Forty L; Florio AD; Green E; Jones L; Gordon-Smith K; Landen M; Hultman C; Jureus A; Bergen S; McCarroll S; Moran J; Smoller JW; Chambert K; Belliveau RA
Mol Psychiatry; 2016 Sep; 21(9):1290-7. PubMed ID: 26503763
[TBL] [Abstract][Full Text] [Related]
29. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
30. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
[TBL] [Abstract][Full Text] [Related]
31. Evidence of associations between bipolar disorder and the brain-derived neurotrophic factor (BDNF) gene.
Sears C; Markie D; Olds R; Fitches A
Bipolar Disord; 2011; 13(7-8):630-7. PubMed ID: 22085476
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
[TBL] [Abstract][Full Text] [Related]
33. Response to lithium in bipolar disorder: clinical and genetic findings.
Rybakowski JK
ACS Chem Neurosci; 2014 Jun; 5(6):413-21. PubMed ID: 24625017
[TBL] [Abstract][Full Text] [Related]
34. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
35. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK
Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793
[TBL] [Abstract][Full Text] [Related]
36. Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder.
McCarthy MJ; Wei H; Nievergelt CM; Stautland A; Maihofer AX; Welsh DK; Shilling P; Alda M; Alliey-Rodriguez N; Anand A; Andreasson OA; Balaraman Y; Berrettini WH; Bertram H; Brennand KJ; Calabrese JR; Calkin CV; Claasen A; Conroy C; Coryell WH; Craig DW; D'Arcangelo N; Demodena A; Djurovic S; Feeder S; Fisher C; Frazier N; Frye MA; Gage FH; Gao K; Garnham J; Gershon ES; Glazer K; Goes F; Goto T; Harrington G; Jakobsen P; Kamali M; Karberg E; Kelly M; Leckband SG; Lohoff F; McInnis MG; Mondimore F; Morken G; Nurnberger JI; Obral S; Oedegaard KJ; Ortiz A; Ritchey M; Ryan K; Schinagle M; Schoeyen H; Schwebel C; Shaw M; Shekhtman T; Slaney C; Stapp E; Szelinger S; Tarwater B; Zandi PP; Kelsoe JR
Neuropsychopharmacology; 2019 Feb; 44(3):620-628. PubMed ID: 30487653
[TBL] [Abstract][Full Text] [Related]
37. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.
Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924
[TBL] [Abstract][Full Text] [Related]
38. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder.
Nassan M; Croarkin PE; Luby JL; Veldic M; Joshi PT; McElroy SL; Post RM; Walkup JT; Cercy K; Geske JR; Wagner KD; Cuellar-Barboza AB; Casuto L; Lavebratt C; Schalling M; Jensen PS; Biernacka JM; Frye MA
Bipolar Disord; 2015 Sep; 17(6):645-52. PubMed ID: 26528762
[TBL] [Abstract][Full Text] [Related]
39. Interaction between BDNF rs6265 Met allele and low family cohesion is associated with smaller left hippocampal volume in pediatric bipolar disorder.
Zeni CP; Mwangi B; Cao B; Hasan KM; Walss-Bass C; Zunta-Soares G; Soares JC
J Affect Disord; 2016 Jan; 189():94-7. PubMed ID: 26432032
[TBL] [Abstract][Full Text] [Related]
40. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
